The Hemostatic Effectiveness of "HANBIO" Gauze During Non-emergent Gynecology Surgery. (NCT06715696) | Clinical Trial Compass
CompletedNot Applicable
The Hemostatic Effectiveness of "HANBIO" Gauze During Non-emergent Gynecology Surgery.
Taiwan40 participantsStarted 2024-12-15
Plain-language summary
The objective of this study is to collect the hemostatic effectiveness and device safety data of "HANBIO" Gauze in subjects have acute wound result from gynecology surgery.
Who can participate
Age range20 Years – 70 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female between 20 and 70 years of age.
* Subject scheduled for a non-emergent, gynecological surgery.
* Subject has an identified bleeding site/area intraoperatively.
* Subject is willing to comply with all aspects of the study and have signed informed consent form.
Exclusion Criteria:
* Pregnant or lactating female.
* The wound is chronic wound that not healed within 8 weeks, e.g. ulcers.
* The wound is caused by radiation or burns.
* Subject is sensitive or allergic to collagen.
* Subject is sensitive or allergic to polyester (PET).
* Subject has medical history of coagulation disorder or disease (e.g., hemophilia, thrombocytopenia).
* Subject receives anticoagulants or antiplatelets.
* Subject plans to receive other hemostatic gauze/dressing/agent/medical device as primary hemostasis.
* Subject has participated in another clinical trial within the past 30 days.
* Subjects with any pre-operative or intra-operative findings that may preclude conduct of the study procedure or unable to evaluate the outcomes.